These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 22289804)

  • 1. Predicting the development of mild cognitive impairment: a new use of pattern recognition.
    Cui Y; Sachdev PS; Lipnicki DM; Jin JS; Luo S; Zhu W; Kochan NA; Reppermund S; Liu T; Trollor JN; Brodaty H; Wen W
    Neuroimage; 2012 Apr; 60(2):894-901. PubMed ID: 22289804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting progression to dementia in elderly subjects with mild cognitive impairment using both cognitive and neuroimaging predictors.
    Peters F; Villeneuve S; Belleville S
    J Alzheimers Dis; 2014; 38(2):307-18. PubMed ID: 23963293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability and validity of A Quick Test of Cognitive Speed for detecting early-stage dementia in elderly Japanese.
    Takahashi F; Awata S; Sakuma N; Inagaki H; Ijuin M
    Psychogeriatrics; 2012 Jun; 12(2):75-82. PubMed ID: 22712639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated detection of amnestic mild cognitive impairment in community-dwelling elderly adults: a combined spatial atrophy and white matter alteration approach.
    Cui Y; Wen W; Lipnicki DM; Beg MF; Jin JS; Luo S; Zhu W; Kochan NA; Reppermund S; Zhuang L; Raamana PR; Liu T; Trollor JN; Wang L; Brodaty H; Sachdev PS
    Neuroimage; 2012 Jan; 59(2):1209-17. PubMed ID: 21864688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalizability of the disease state index prediction model for identifying patients progressing from mild cognitive impairment to Alzheimer's disease.
    Hall A; Muñoz-Ruiz M; Mattila J; Koikkalainen J; Tsolaki M; Mecocci P; Kloszewska I; Vellas B; Lovestone S; Visser PJ; Lötjonen J; Soininen H; ; ;
    J Alzheimers Dis; 2015; 44(1):79-92. PubMed ID: 25201784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
    Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
    Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Informant Questionnaire on Cognitive Decline in the Elderly individuals in screening mild cognitive impairment with or without functional impairment.
    Li F; Jia XF; Jia J
    J Geriatr Psychiatry Neurol; 2012 Dec; 25(4):227-32. PubMed ID: 23172761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting decline in mild cognitive impairment: a prospective cognitive study.
    Belleville S; Gauthier S; Lepage E; Kergoat MJ; Gilbert B
    Neuropsychology; 2014 Jul; 28(4):643-52. PubMed ID: 24588699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment in instrumental activities of daily living with high cognitive demand is an early marker of mild cognitive impairment: the Sydney memory and ageing study.
    Reppermund S; Brodaty H; Crawford JD; Kochan NA; Draper B; Slavin MJ; Trollor JN; Sachdev PS
    Psychol Med; 2013 Nov; 43(11):2437-45. PubMed ID: 23308393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.
    Modrego PJ; Fayed N; Pina MA
    Am J Psychiatry; 2005 Apr; 162(4):667-75. PubMed ID: 15800137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olfactory identification and cognitive performance in community-dwelling older adults with mild cognitive impairment.
    Makizako M; Makizako H; Doi T; Uemura K; Tsutsumimoto K; Miyaguchi H; Shimada H
    Chem Senses; 2014 Jan; 39(1):39-46. PubMed ID: 24200528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
    Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M
    Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
    J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia.
    Yu P; Dean RA; Hall SD; Qi Y; Sethuraman G; Willis BA; Siemers ER; Martenyi F; Tauscher JT; Schwarz AJ
    J Alzheimers Dis; 2012; 32(2):373-85. PubMed ID: 22796873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
    Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
    J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between small cerebral white matter lesions and cognitive function in patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Makino T; Umegaki H; Suzuki Y; Yanagawa M; Nonogaki Z; Nakashima H; Kuzuya M
    Geriatr Gerontol Int; 2014 Oct; 14(4):819-26. PubMed ID: 24215176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clock Drawing Test and the diagnosis of amnestic mild cognitive impairment: can more detailed scoring systems do the work?
    Rubínová E; Nikolai T; Marková H; Siffelová K; Laczó J; Hort J; Vyhnálek M
    J Clin Exp Neuropsychol; 2014; 36(10):1076-83. PubMed ID: 25486502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.